Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity.
about
Neuroinflammation and psychiatric illnessNeuron-glia interaction as a possible glue to translate the mind-brain gap: a novel multi-dimensional approach toward psychology and psychiatryProfile of minocycline and its potential in the treatment of schizophreniaQuinolinic acid, the inescapable neurotoxinNeurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidenceToxin-Induced Experimental Models of Learning and Memory ImpairmentQuinolinic Acid Responses during Interferon-α-Induced Depressive Symptomatology in Patients with Chronic Hepatitis C Infection - A Novel Aspect for Depression and Inflammatory HypothesisA Neurophysiological Perspective on a Preventive Treatment against Schizophrenia Using Transcranial Electric Stimulation of the Corticothalamic PathwayAntigliadin Antibodies (AGA IgG) Are Related to Neurochemistry in Schizophrenia.A critical review of pro-cognitive drug targets in psychosis: convergence on myelination and inflammation.Neurological and psychiatric disorders as a neuroglial failure.Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?Depression, strokes and dementia: new biological insights into an unfortunate pathway.Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorderThe suicide prevention effect of lithium: more than 20 years of evidence-a narrative reviewMorphological features of microglial cells in the hippocampal dentate gyrus of Gunn rat: a possible schizophrenia animal modelReduced density of glutamine synthetase immunoreactive astrocytes in different cortical areas in major depression but not in bipolar I disorderAcute Psychological Stress Modulates the Expression of Enzymes Involved in the Kynurenine Pathway throughout Corticolimbic Circuits in Adult Male Rats.Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.Immune system disturbances in schizophrenia.Beta-trace Protein as a new non-invasive immunological Marker for Quinolinic Acid-induced impaired Blood-Brain Barrier Integrity.Behavioral sequelae of astrocyte dysfunction: focus on animal models of schizophrenia.Antineuronal antibodies against neurotransmitter receptors and synaptic proteins in schizophrenia: current knowledge and clinical implications.Employing proteomics to unravel the molecular effects of antipsychotics and their role in schizophrenia.Role of Kynurenine Metabolism Pathway Activation in Major Depressive Disorders.Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.Pharmacotherapy in Generalized Anxiety Disorder: Novel Experimental Medicine Models and Emerging Drug Targets.Peripheral inflammatory cytokines and immune balance in Generalised Anxiety Disorder: Case-controlled study.Dopamine stimulates propagation of Toxoplasma gondii tachyzoites in human fibroblast and primary neonatal rat astrocyte cell cultures.Microglial Over-Activation by Social Defeat Stress Contributes to Anxiety- and Depressive-Like Behaviors.Angiogenic, neurotrophic, and inflammatory system SNPs moderate the association between birth weight and ADHD symptom severity.Revisiting the tryptophan-serotonin deficiency and the inflammatory hypotheses of major depression in a biopsychosocial approach.Oxidative stress in drug-naïve first episode patients with schizophrenia and major depression: effects of disease acuity and potential confounders.Decreased quinolinic acid in the hippocampus of depressive patients: evidence for local anti-inflammatory and neuroprotective responses?Astrogliopathology: a central element of neuropsychiatric diseases?Anti-Yo Antibodies in Children With ADHD: First Results About Serum Cytokines.Adjunctive sarcosine plus benzoate improved cognitive function in chronic schizophrenia patients with constant clinical symptoms: A randomised, double-blind, placebo-controlled trial.An Expanded Neuroimmunomodulation Axis: sCD83-Indoleamine 2,3-Dioxygenase—Kynurenine Pathway and Updates of Kynurenine Pathway in Neurologic Diseases.Cerebrovascular dysfunction with stress and depression
P2860
Q21245244-34A012AC-F12C-4FC3-B5AB-53422A82BD64Q26825959-9D067CD1-8EFD-4B76-B761-4B81F850F1C3Q26864400-D55040B6-E8D4-40FC-85CE-DE480BA53397Q26991715-18E990E2-AFE4-4A37-B56C-CF3B6FEC6625Q26999061-F1F84A8B-422A-4D2D-BA2F-22E661CF8427Q28075913-0B50D53F-CCB8-4A63-B782-6C7B620ABAECQ28607691-745D9896-5502-4A7A-BC73-42535D94144FQ33607904-AEBE2CC7-80F1-4CEC-807D-7AD34E107EA0Q33809544-D1F8D5A2-6ECD-4B84-A524-05CBC07240A0Q34405264-66F25C70-413E-4E1A-8229-64560267E222Q34770769-72B86F12-E8C7-4660-8317-6F8076106EDEQ35225947-35AD7066-9F84-4E20-8DB6-A7DC662204F7Q35636066-39B5BF82-ECA8-4B08-9F3C-A2EEFB1D0B53Q35647362-285510D8-85EB-4E2E-814E-D5B1D40AA587Q35858926-EF946724-5C4B-4269-8CCE-5598736BE871Q35907956-765D54E7-6852-4184-B1C1-3635EBB17E75Q35933481-2B744A13-1EB0-45C7-9569-DCED186A470CQ36447182-A49A05E1-C385-4AE7-9FBD-87C056DF24FFQ36579965-A9797558-5BCC-4EF3-9B1B-E126B5478908Q36665332-C3A07F46-A22C-4B1E-86E4-8F8286E63CFFQ37344544-AE18AE1B-4D6B-4E73-855D-30AD968271DDQ37690195-82661176-8F8A-41A3-87EE-7EEA4A16D284Q38281865-0875B72C-1741-46D1-8CB4-C2A843F1624EQ38365916-1BD91F1F-A45D-415F-B2FB-19B90461B184Q38672722-94D4DBC7-248B-4FFA-9E27-4605CAF27045Q38843539-0F4B967E-E967-485C-BADC-7BC5F1906018Q39130393-BE5114FD-D4BC-4518-B570-C0570FF006A8Q39183229-C8BA047C-9B03-4848-8F39-785531FD7F40Q40349578-C8AEA17C-B0A1-4F8C-94F1-EFCD85C72214Q44974849-40D94FFD-3147-4C5F-A6A1-66039C16210AQ45369024-F98827ED-5E5E-4FB4-8C9D-5BFA5B6F7E3DQ46496399-70DBAED0-A018-403E-99B2-7A6B5FC285FDQ47163480-640589A4-F114-4ECC-943F-592F128A318CQ47787773-313E1603-B9B2-49F0-A7DA-553227ABA797Q48173300-9E78369B-B205-4A34-9B88-21924B0A3202Q48391684-8632E435-FBBB-400E-828A-A26A12D21513Q50531503-CBCB2995-3704-4C35-83CC-7D9CC91060C2Q50750840-9237751B-C77D-41D2-9FEB-D93D6033924FQ55381445-8714CDD9-7965-4C8A-B992-BCD6C6E5E761Q57146613-11D2640A-7ADA-4C58-9F8D-2AAAEE95CFDA
P2860
Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bridging the gap between the i ...... blood-brain barrier integrity.
@en
Bridging the gap between the i ...... blood-brain barrier integrity.
@nl
type
label
Bridging the gap between the i ...... blood-brain barrier integrity.
@en
Bridging the gap between the i ...... blood-brain barrier integrity.
@nl
prefLabel
Bridging the gap between the i ...... blood-brain barrier integrity.
@en
Bridging the gap between the i ...... blood-brain barrier integrity.
@nl
P2093
P2860
P50
P1476
Bridging the gap between the i ...... blood-brain barrier integrity
@en
P2093
Aye-Mu Myint
Bernhard Bogerts
Hans-Gert Bernstein
Tomasz Gos
P2860
P304
P356
10.3109/15622975.2011.583941
P577
2011-06-28T00:00:00Z